A study published on the use of hydroxychloroquine in Brazil to treat Covid-19 has found the drug ineffective, the latest blow to President Jair Bolsonaro's push for its widespread use, AFP reported.

The clinical trial, conducted at 55 hospitals across Brazil and published in the New England Journal of Medicine, tested whether hydroxychloroquine improved the condition of patients with mild to moderate cases of Covid-19, alone or in combination with the antibiotic azithromycin.

Opinion

Editorial

Climate choices
Updated 15 Jun, 2026

Climate choices

The country is confronting increasingly volatile weather patterns with consequences for agriculture, infrastructure, public health and economic planning.
Brief opening
15 Jun, 2026

Brief opening

WE have been here before. Throughout the weekend, there was great anticipation that a tentative framework for peace...
Environmental disaster
15 Jun, 2026

Environmental disaster

IT was a heartbreaking sight. A recent news report in these pages carried a picture of a sea turtle lying half ...
Budget presser
Updated 14 Jun, 2026

Budget presser

If the FBR falters, the government will find itself in hot water sooner rather than later.
Muharram precautions
14 Jun, 2026

Muharram precautions

WITH Muharram due to start next week, the authorities have already begun annual exercises to ensure that the ...
Blood bequests
14 Jun, 2026

Blood bequests

WORLD Blood Donor Day offers a moment of “gratitude, advocacy and renewed commitment” for thalassaemia patients...